Clincosm LogoSign in Get a demo

HCV

Showing 26 - 47 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

Completed
  • HCV
  • Beijing, Beijing, China
    Peking University People's hospital
Jul 25, 2020

Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)

Completed
Has Results
  • Hepatitis C
  • HCV
  • Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
  • Ribavirin 200Mg Tablet
  • Palo Alto, California
  • +30 more
Feb 17, 2020

ive Non Invasive Diagnostic Modalities and Predictive Model for

Withdrawn
  • HBV
  • +2 more
    • New Delhi, Delhi, India
      Institute of liver and Biliary Sciences
    Oct 7, 2019

    Vitamin D Status on Virological Response in HCV Infection

    Unknown status
    • HCV
      • (no location specified)
      Feb 3, 2019

      Gaucher Disease, HCV Trial in Mansoura (Ledipasvir/Sofosbuvir)

      Unknown status
      • Gaucher Disease
      • HCV
      • Mansoura, Dakahliya, Egypt
        Mansoura University Children Hospital, Ped Gastroenteroloy and H
      Oct 26, 2018

      Hepatocellular Carcinoma, HCC, Hepatitis C Trial in New York (Automated reminders, Patient navigation)

      Completed
      • Hepatocellular Carcinoma
      • +3 more
      • Automated reminders
      • Patient navigation
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Oct 10, 2018

      Non-alcoholic Steatohepatitis, Chronic Liver Disease, HCV Trial in Worldwide (Eltrombopag, Placebo)

      Terminated
      Has Results
      • Non-alcoholic Steatohepatitis
      • +10 more
      • Birmingham, Alabama
      • +106 more
      Sep 13, 2018

      Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent

      Unknown status
      • HCV
      • RAVS In relapsed and resistent cases
      • (no location specified)
      Jun 27, 2018

      is Designed to Monitor Long-Term Efficacy and Safety of

      Completed
      • HCV
        • Dallas, Texas
        • +2 more
        Feb 5, 2018

        Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

        Completed
        • Hepatitis C
        • +2 more
          • New York, New York
            Icahn School of Medicine at Mount Sinai
          Jan 16, 2018

          HCV Trial in Hangzhou (Danoprevir, Ritonavir, Ravidasvir)

          Completed
          • HCV
          • Hangzhou, Zhejiang, China
            The first hospital of Zhejiang province
          Jan 14, 2018

          Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530, ribavirin (RBV), ABT-493/ABT-530)

          Completed
          Has Results
          • Chronic Hepatitis C
          • +3 more
          • ABT-493, ABT-530
          • +2 more
          • (no location specified)
          Aug 17, 2017

          HIV, HCV Trial run by the NIAID (Albinterferon, Ribavirin, Albuferon)

          Completed
          • HIV Infections
          • HCV
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jun 30, 2017

          HCV Trial (Sofosbuvir-Simeprevir, Sofosbuvir-Ribavirin)

          Completed
          • HCV
          • (no location specified)
          Feb 27, 2017

          Chronic Hepatitis C, CHC, HCV Trial in Auckland, Christchurch (VX-135, Daclatasvir)

          Completed
          • Chronic Hepatitis C
          • +3 more
          • Auckland, New Zealand
          • +1 more
          Nov 30, 2015

          Hepatitis C, HCV, Chronic Hepatitis C Infection Trial in United States (ABT-450, ABT-072, Ribavirin)

          Completed
          Has Results
          • Hepatitis C
          • +3 more
          • Los Angeles, California
          • +3 more
          Dec 29, 2014

          Hepatitis C, HCV, Chronic Hepatitis C Infection Trial in Puerto Rico, United States (ABT-450, ABT-072, ABT-333)

          Completed
          Has Results
          • Hepatitis C
          • +3 more
          • Phoenix, Arizona
          • +25 more
          Dec 29, 2014

          Hepatitis C, HCV, Tuberculosis Trial (TMC435350, Rifampin, TMC435350+rifampin)

          Completed
          • Hepatitis C
          • +4 more
          • (no location specified)
          Apr 17, 2013

          Hepatitis C, HCV, HIV Trial (Efavirenz; Tenofovir disoproxil fumarate; Telaprevir)

          Completed
          • Hepatitis C
          • +3 more
          • Efavirenz; Tenofovir disoproxil fumarate; Telaprevir
          • (no location specified)
          Dec 16, 2010

          Hepatitis C, HCV Trial (TMC435350)

          Completed
          • Hepatitis C
          • HCV
          • (no location specified)
          Apr 26, 2010

          HCV Trial (TMC435350)

          Completed
          • HCV
          • (no location specified)
          Apr 26, 2010

          HCV Trial in Tacoma ([14C]-PF-00868554)

          Completed
          • HCV
          • Tacoma, Washington
            Pfizer Investigational Site
          Mar 6, 2009